Literature DB >> 29320649

Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.

Kenneth G Saag1, Jeffrey Petersen2, Andreas Grauer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29320649     DOI： 10.1056/NEJMc1714810

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Cellular senescence in bone.

Authors:  Joshua N Farr; Sundeep Khosla
Journal:  Bone       Date:  2019-01-16       Impact factor: 4.398

Review 2.  A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.

Authors:  S Singh; S Dutta; S Khasbage; T Kumar; J Sachin; J Sharma; S B Varthya
Journal:  Osteoporos Int       Date:  2021-08-25       Impact factor: 5.071

Review 3.  Treatment of Osteoporosis, with a Focus on 2 Monoclonal Antibodies.

Authors:  Biao Chang; Qi Quan; Yunqi Li; Haixia Qiu; Jiang Peng; Ying Gu
Journal:  Med Sci Monit       Date:  2018-12-03

4.  Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and Fractures.

Authors:  Jie Zheng; Winfried Maerz; Ingrid Gergei; Marcus Kleber; Christiane Drechsler; Christoph Wanner; Vincent Brandenburg; Sjur Reppe; Kaare M Gautvik; Carolina Medina-Gomez; Enisa Shevroja; Arthur Gilly; Young-Chan Park; George Dedoussis; Eleftheria Zeggini; Mattias Lorentzon; Petra Henning; Ulf H Lerner; Karin H Nilsson; Sofia Movérare-Skrtic; Denis Baird; Benjamin Elsworth; Louise Falk; Alix Groom; Terence D Capellini; Elin Grundberg; Maria Nethander; Claes Ohlsson; George Davey Smith; Jonathan H Tobias
Journal:  J Bone Miner Res       Date:  2019-08-02       Impact factor: 6.741

5.  Circulating Sclerostin Levels Are Positively Related to Coronary Artery Disease Severity and Related Risk Factors.

Authors:  Monika Frysz; Ingrid Gergei; Hubert Scharnagl; George Davey Smith; Jie Zheng; Deborah A Lawlor; Markus Herrmann; Winfried Maerz; Jon H Tobias
Journal:  J Bone Miner Res       Date:  2021-12-09       Impact factor: 6.390

6.  Sclerostin expression in trabecular bone is downregulated by osteoclasts.

Authors:  Masanori Koide; Teruhito Yamashita; Kohei Murakami; Shunsuke Uehara; Keigo Nakamura; Midori Nakamura; Mai Matsushita; Toshiaki Ara; Hisataka Yasuda; Josef M Penninger; Naoyuki Takahashi; Nobuyuki Udagawa; Yasuhiro Kobayashi
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.